Serological status of Canadian cattle for brucellosis, anaplasmosis, and bluetongue in 2007-2008.

A national bovine serological survey was conducted to confirm that the prevalence of brucellosis, bluetongue, and anaplasmosis does not exceed 0.02% (95% confidence) in live cattle in Canada. Sampling consisted of a systematic random sample of 15 482 adult cattle slaughtered in federally inspected abattoirs, stratified by province. Samples were tested to detect antibodies for brucellosis, bluetongue, and anaplasmosis. All samples were negative for brucellosis. Three samples were seroreactors to bluetongue, 2 of which originated from the Okanagan Valley in British Columbia and 1 from Ontario, which after follow-up, was considered an atypical result. A total of 244 samples were seroreactors to Anaplasma and follow-up identified infection in Saskatchewan, Manitoba, and Quebec. In conclusion, the Canadian cattle population remains free of brucellosis and free of bluetongue outside the Okanagan Valley. Canada is no longer free of anaplasmosis and will be unable to claim freedom until eradication measures are completed.

RésuméStatut sérologique des bovins canadiens à l'égard de la brucellose, l'anaplasmose et la fièvre catarrhale du mouton en 2007­2008. L'enquête sérologique sur les bovins a été menée à l'échelle nationale afin de confirmer que la brucellose, la fièvre catarrhale du mouton et l'anaplasmose demeurent à une prévalence inférieure à 0,02 % (intervalle de confiance de 95 %) dans le cheptel bovin canadien. Un échantillonnage systématique de 15 482 bovins adultes a été effectué dans les abattoirs sous inspection fédérale, en stratifiant par province. Tous les échantillons se sont avérés négatifs en sérologie pour la brucellose. Une réaction sérologique a été identifiée pour la fièvre catarrhale du mouton chez trois bovins, dont deux provenaient de la vallée de l'Okanagan en Colombie-Britanique. L'autre réacteur provenait d'une ferme d'Ontario, où, après investigation, les résultats ont été considérés atypiques. Une réaction sérologique à l'anaplasmose a été détectée dans 244 échantillons. Les investigations ont permis d'identifier des fermes infectées en Saskatchewan, au Manitoba et au Québec. Le cheptel bovin canadien demeure donc indemne de la brucellose, et de la fièvre catarrhale du mouton à l'exclusion des bovins la vallée de l'Okanagan en Colombie-Britannique. Le Canada n'est plus considéré comme étant indemne de l'anaplasmose et ne pourra réclamer ce statut tant que l'éradication ne sera pas terminée.(Traduit par les auteurs).

Vaccination against foot-and-mouth disease: the implications for Canada.

Vaccination of susceptible animals against foot-and-mouth disease (FMD) is a well established strategy for helping to combat the disease. Traditionally, FMD vaccine has been used to control a disease incursion in countries where the disease has been endemic rather than in countries considered free of the disease. In 2001, the use of vaccine was considered but not implemented in the United Kingdom (1), whereas vaccine was used to help to control FMD in The Netherlands (2,3). Canadian contingency plans provide for the use of vaccine; Canada is a member of the North American Foot-and-Mouth Disease Vaccine Bank, which could supply vaccine if needed. This article explains why Canada might use FMD vaccine to combat an outbreak and the factors that are relevant to the disposal of vaccinated animals and their products. It concludes that vaccination is an important mechanism in Canada's preparedness for an outbreak of FMD and that products from vaccinated animals are safe for human consumption.